Mirati Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2014 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Mirati Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2014 to Q3 2023.
  • Mirati Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was -82.2 %, a 36% decline year-over-year.
  • Mirati Therapeutics, Inc. annual Return On Equity for 2022 was -66.1 %, a 38.2% decline from 2021.
  • Mirati Therapeutics, Inc. annual Return On Equity for 2021 was -47.8 %, a 5.92% decline from 2020.
  • Mirati Therapeutics, Inc. annual Return On Equity for 2020 was -45.1 %, a 16.8% increase from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -82.2 -21.7 -36% Jul 1, 2023 Sep 30, 2023
Q2 2023 -79.4 -26.1 -49.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -71.9 -19.7 -37.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -66.1 -18.3 -38.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -60.4 -20.4 -51% Jul 1, 2022 Sep 30, 2022
Q2 2022 -53.2 -7.61 -16.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -52.2 -9.12 -21.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -47.8 -2.67 -5.92% Oct 1, 2021 Dec 31, 2021
Q3 2021 -40 +20 +33.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -45.6 +11.4 +20% Apr 1, 2021 Jun 30, 2021
Q1 2021 -43.1 +10.1 +19% Jan 1, 2021 Mar 31, 2021
Q4 2020 -45.1 +9.11 +16.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -60 -11.4 -23.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -57 -8.83 -18.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -53.3 -1.14 -2.19% Jan 1, 2020 Mar 31, 2020
Q4 2019 -54.2 -5.68 -11.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -48.6 -1.81 -3.87% Jul 1, 2019 Sep 30, 2019
Q2 2019 -48.2 +3.41 +6.61% Apr 1, 2019 Jun 30, 2019
Q1 2019 -52.1 +10.2 +16.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 -48.6 +23 +32.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -46.8 +50 +51.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 -51.6 +50.3 +49.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -62.3 +44.9 +41.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -71.6 +40.1 +35.9% Oct 1, 2017 Dec 31, 2017
Q3 2017 -96.8 -7.76 -8.71% Jul 1, 2017 Sep 30, 2017
Q2 2017 -102 -27.4 -36.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -107 -34.2 -46.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -112 -42.6 -61.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -89.1 -9.37 -11.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 -74.5 +25.5 +25.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -73 +50.8 +41% Jan 1, 2016 Mar 31, 2016
Q4 2015 -69.1 +144 +67.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -79.7 +143 +64.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -100 +1.16K +92.1% Apr 1, 2015 Jun 30, 2015
Q1 2015 -124 +1K +89% Jan 1, 2015 Mar 31, 2015
Q4 2014 -213 Oct 1, 2014 Dec 31, 2014
Q3 2014 -223 Jul 1, 2014 Sep 30, 2014
Q2 2014 -1.26K Apr 1, 2014 Jun 30, 2014
Q1 2014 -1.12K Jan 1, 2014 Mar 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.